tirzepatide for heart failure with preserved ejection fraction and obesity benefits obese HFpEF patients without type 2 diabetes Lilly's Tirzepatide Reduces Heart Failure

Food stays in your stomach longer, so you tend to feel full for longer

However, early findings suggest that GLP-1 receptor agonists may actually have some protective effects in the gut

Throughout the clinical trials, nausea (12%-24%), diarrhoea (12%-22%), and vomiting (2%-13%) were the most commonly reported gastrointestinal events associated with tirzepatide [54,55,56], consistent with the results of this study

In a healthy body, GLP-1 binds to its receptor, triggers insulin release, suppresses glucagon, and tells the brain the stomach is full

Storing a weight-loss pen

Melanogenesis can protect the hypodermis, which is the layer beneath the skin, from harmful UV-B rays